Page last updated: 2024-10-30

kynurenic acid and Myocardial Ischemia

kynurenic acid has been researched along with Myocardial Ischemia in 1 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wyant, GA1
Yu, W1
Doulamis, IP1
Nomoto, RS1
Saeed, MY1
Duignan, T1
McCully, JD1
Kaelin, WG1

Other Studies

1 other study available for kynurenic acid and Myocardial Ischemia

ArticleYear
Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.
    Science (New York, N.Y.), 2022, 08-05, Volume: 377, Issue:6606

    Topics: Adenosine Triphosphate; Animals; ATPase Inhibitory Protein; Humans; Kynurenic Acid; Mice; Mitochondr

2022